Phase II Study of ABI-007 by Tri-weekly Schedule for Patients With Unresectable or Recurrent Gastric Cancer Refractory to 5-FU Containing Regimen.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2014
At a glance
- Drugs Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 11 Jan 2012 Actual end date (1 Dec 2011) added as reported by ClinicalTrials.gov
- 11 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2011 Planned end date changed from 1 Mar 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.